OrthogenRx

About:

OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices.

Website: http://orthogenrx.com

Twitter/X: orthogenrx

Top Investors: Ben Franklin Technology Partners of Southeastern Pennsylvania, New Age Ventures

Description:

OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices for the treatment of musculoskeletal conditions. The business model utilizes exclusive supply and license agreements for products presently on the market ex-US and seeks generic product approval in the U.S. potentially saving the healthcare system billions in cost. The strategy utilizes existing regulations for an abbreviated regulatory approval for generic devices, analogous to generic drugs.

Total Funding Amount:

$6.51M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Doylestown, Pennsylvania, United States

Founded Date:

2012-09-10

Contact Email:

mdaley(AT)orthogenrx.com

Founders:

Michael Daley

Number of Employees:

11-50

Last Funding Date:

2017-05-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai